No Data
No Data
Unusual Options Activity: MRVL, IONS and Others Attract Market Bets, MRVL V/OI Ratio Reaches 375.0
Ionis Pharmaceuticals, Inc.'s (NASDAQ:IONS) Shareholders Might Be Looking For Exit
Leerink Upgrades Ionis to Outperform, Cites Angelman Drug
Express News | Ionis Pharmaceuticals Shares up 1.3% Premarket After Leerink Partners Raises to Outperform From Market Perform
Express News | Ionis Pharmaceuticals Inc : Leerink Partners Raises Target Price to $62 From $53
Express News | Ionis Pharmaceuticals Inc : Leerink Partners Raises to Outperform From Market Perform
No Data